USANA Health Sciences Inc (USNA) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.17 is considered Undervalued compared with the five-year average of 17.50. The fair price of USANA Health Sciences Inc (USNA) is between 26.75 to 38.78 according to relative valuation method. Compared to the current price of 20.09 USD , USANA Health Sciences Inc By Undervalued By 24.9%.

Relative Value

Fair Zone

26.75-38.78

Current Price：20.09

24.9%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is USANA Health Sciences Inc (USNA) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

USANA Health Sciences Inc (USNA) has a current Price-to-Book (P/B) ratio of 0.67. Compared to its 3-year average P/B ratio of 1.64, the current P/B ratio is approximately -59.09% higher. Relative to its 5-year average P/B ratio of 2.61, the current P/B ratio is about -74.23% higher. USANA Health Sciences Inc (USNA) has a Forward Free Cash Flow (FCF) yield of approximately 5.26%. Compared to its 3-year average FCF yield of 7.20%, the current FCF yield is approximately -26.96% lower. Relative to its 5-year average FCF yield of 7.18%, the current FCF yield is about -26.73% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for USNA competitors is 101.96, providing a benchmark for relative valuation. USANA Health Sciences Inc Corp (USNA.N) exhibits a P/S ratio of 0.40, which is -99.61% above the industry average. Given its robust revenue growth of 5.89%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of USNA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of USNA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is USNA currently overvalued or undervalued?

USANA Health Sciences Inc (USNA) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.17 is considered Undervalued compared with the five-year average of 17.50. The fair price of USANA Health Sciences Inc (USNA) is between 26.75 to 38.78 according to relative valuation method. Compared to the current price of 20.09 USD, USANA Health Sciences Inc is Undervalued By 24.90%.

What is USANA Health Sciences Inc (USNA) fair value?

USNA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of USANA Health Sciences Inc (USNA) is between 26.75 to 38.78 according to relative valuation method.

How does USNA's valuation metrics compare to the industry average?

The average P/S ratio for USNA's competitors is 101.96, providing a benchmark for relative valuation. USANA Health Sciences Inc Corp (USNA) exhibits a P/S ratio of 0.40, which is -99.61% above the industry average. Given its robust revenue growth of 5.89%, this premium appears unsustainable.

What is the current P/B ratio for USANA Health Sciences Inc (USNA) as of Mar 03 2026?

As of Mar 03 2026, USANA Health Sciences Inc (USNA) has a P/B ratio of 0.67. This indicates that the market values USNA at 0.67 times its book value.

What is the current FCF Yield for USANA Health Sciences Inc (USNA) as of Mar 03 2026?

As of Mar 03 2026, USANA Health Sciences Inc (USNA) has a FCF Yield of 5.26%. This means that for every dollar of USANA Health Sciences Inc's market capitalization, the company generates 5.26 cents in free cash flow.

What is the current Forward P/E ratio for USANA Health Sciences Inc (USNA) as of Mar 03 2026?

As of Mar 03 2026, USANA Health Sciences Inc (USNA) has a Forward P/E ratio of 11.17. This means the market is willing to pay $11.17 for every dollar of USANA Health Sciences Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for USANA Health Sciences Inc (USNA) as of Mar 03 2026?

As of Mar 03 2026, USANA Health Sciences Inc (USNA) has a Forward P/S ratio of 0.40. This means the market is valuing USNA at $0.40 for every dollar of expected revenue over the next 12 months.

USNA Valuation